This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:othertreatments:antifungals [08.02.2017] – [Types of antifungal agents] sallieq | home:othertreatments:antifungals [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 6: | Line 6: | ||
Antifungal agents such as fluconazole (Diflucan) are sometimes prescribed to treat fungal infections, of which //Candida// is one kind. While some patients have reported feeling better after taking antifungal agents, antifungals interfere with immune function. | Antifungal agents such as fluconazole (Diflucan) are sometimes prescribed to treat fungal infections, of which //Candida// is one kind. While some patients have reported feeling better after taking antifungal agents, antifungals interfere with immune function. | ||
- | The antifungals directly inhibit the enzyme CYP27B1, which is needed for the mitichondria in the macrophages to convert 25-D to 1,25-D.(({{pubmed> | + | The antifungals directly inhibit the enzyme CYP27B1, which is needed for the mitichondria in the macrophages to convert 25-D to 1,25-D.(({{pmid> |
By increasing levels of 25-D and therefore inhibiting immunopathology, | By increasing levels of 25-D and therefore inhibiting immunopathology, | ||
Line 16: | Line 16: | ||
Patient symptom scores were a poor predictor of yeast infections based on yeast culture results. ... Self-reported symptoms are not reliable for diagnosis. | Patient symptom scores were a poor predictor of yeast infections based on yeast culture results. ... Self-reported symptoms are not reliable for diagnosis. | ||
- | //**Susan Hoffstetter** et al.// (({{pubmed> | + | //**Susan Hoffstetter** et al.// (({{pmid> |
Line 59: | Line 59: | ||
//bobi August 2017//</ | //bobi August 2017//</ | ||
+ | < | ||
+ | Grateful Survivor | ||
+ | |||
+ | |||
+ | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
Line 69: | Line 74: | ||
From: Dr. Greg Blaney | From: Dr. Greg Blaney | ||
Date: 2010-07-04 14:39:15 | Date: 2010-07-04 14:39:15 | ||
- | Reply: | + | Reply: |
< | < | ||
Line 76: | Line 81: | ||
* Legacy content | * Legacy content | ||
- | * http:// | + | * https:// |
* | * | ||
Line 82: | Line 87: | ||
- | 1. Natamycin Inhibits Vacuole Fusion at the Priming Phase via a Specific Interaction with Ergoste | + | 1. Natamycin Inhibits Vacuole Fusion at the Priming Phase via a Specific Interaction with Ergoste |
- | 2. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. | + | 2. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. |
Line 92: | Line 97: | ||
While a search in wikapedia states under natamycin saftety that, “Natamycin lacks acute toxicity" | While a search in wikapedia states under natamycin saftety that, “Natamycin lacks acute toxicity" | ||
</ | </ | ||
- | ===== References ===== | + | ===== References =====</ |